List view / Grid view
15 April 2016 | By Victoria White, Digital Content Producer
Researchers from MIT and MGH have developed a small, implantable device that delivers chemotherapy drugs directly to pancreatic tumours...
13 April 2016 | By Victoria White, Digital Content Producer
The effects of LSD on the human brain have been visualised for the first time and may lead to new treatments for psychiatric disorders...
12 April 2016 | By Quotient Clinical
Quotient Clinical, the Translational Pharmaceutics® company, has announced that it has completed its 100th RapidFACT...
12 April 2016 | By Victoria White, Digital Content Producer
In addition to the discovery, development and commercialisation of new therapies, the companies will focus on technology development of the CRISPR/Cas platform...
12 April 2016 | By Merck KGaA
As a leading provider of antibodies for cell signaling research, EMD Millipore is advancing life science research and therapeutic development...
12 April 2016 | By Caroline Richards, Editor, Drug Target Review
Here, Caroline Richards, Editor of Drug Target Review, discusses the publication and the opportunities available to authors...
1 April 2016 | By Victoria White
Researchers have determined the structure of the Zika virus, revealing insights critical to the development of effective antiviral treatments and vaccines...
31 March 2016 | By Victoria White
Children with cancer will be offered testing for genetic mutations in their tumours as part of an initiative to personalise children’s cancer treatment...
17 March 2016 | By Victoria White
Scientists have developed a capsule containing cells that have been genetically engineered to produce antibodies against the Abeta...
17 March 2016 | By Merck KGaA
EMD Millipore offers an extensive, focused portfolio of immunoassays and validated antibodies for effective immunoprecipitation of chromatin, RNA-binding proteins, modified histones, and transcriptional proteins...
Long term success for pharmaceutical businesses depends upon harnessing the best tools available to bring safe and effective medicines to market at a competitive price, and to be truly successful, for such drugs to be first in class.
17 March 2016 | By Drug Target Review
In this Drug Targets In-Depth Focus: "The alarming increase in antibioticresistant bacteria", plus "Computational methods for drug repositioning"; and "An overview of Alzheimer’s disease drug targets"...
17 March 2016 | By Caroline Richards
Caroline Richards, Editor of Drug Target Review, invites Michael Springer, Associate Professor of Systems Biology, Harvard Medical School to discuss a laboratory study of a yeast model using microfluidic systems...
17 March 2016 | By Merck KGaA
The CellASIC® ONIX2 Microfluidic System for live cell imaging is easy to use and gives researchers precise environmental control over live cells. By providing dynamic control over drug addition, gas, temperature, media and more, this all in one system is the perfect addition to your microscope to enhance your imaging…
Microfluidic technology has great potential for complementing and, in some instances, replacing the use of animal models in the testing of medicines and in developing personalised treatments for cancer patients.
